EVALUATION OF EFFECTIVENESS OF FIGHT AGAINST FALSIFICATION OF MEDICINES IN UKRAINE: THE VIEW OF PHARMACISTS
DOI:
https://doi.org/10.11603/2312-0967.2020.4.11642Keywords:
drugs, falsification, falsified medicines, pharmacies, pharmaceutical specialists, questionnaires, respondentsAbstract
The aim of the work was to assess the effectiveness of combating drug counterfeiting using a questionnaire survey of specialists from pharmacies in different regions of Ukraine.
Materials and methods of research. Scientific publications on the problem of drug counterfeiting, as well as analysis of survey data of specialists of pharmacies in different regions of Ukraine on the problems of combating drug counterfeiting. The research was conducted using the methods of questionnaires, systematization and generalization.
Results and discussion. According to the results of a questionnaire survey of pharmacy specialists conducted at the national level (13 regions representing the east, west, north, south and center of Ukraine), more than 33% of respondents answered that the share of counterfeit drugs is from 1% to 5%, which is in line with WHO data. Among the signs of drug falsification, respondents mostly attributed “Foreign Language Labeling” (44.85%). Regarding the main sales channels of falsified medicines more than 75% of respondents named e-commerce. Regarding the methods and measures to be used by manufacturers and pharmacies in the fight against drug counterfeiting, about 75% of respondents called compliance with the GMP standard, while more than 64% expect manufacturers to introduce additional protection of drug packaging against counterfeiting, including 44% - mandatory transition to labeling with 2-d bar codes, as well as more than 78% of respondents named the purchase of drugs only from suppliers certified for compliance with GDP.
Conclusion. In order to create an effective system to combat the spread of counterfeit drugs, it is proposed to create a National Program to Combat Counterfeiting of Medicines, as well as to develop practical recommendations for detecting counterfeit drugs and preventing their illicit trafficking for pharmaceutical professionals.
References
A study on the public health and socioeconomic impact of substandard and falsified medical products. WHO, 2017. Available from: https://www.who.int/publications/i/item/study-on-public-health-socioeconomic-impact-substandard-falsified-medical-products-978-92-4-151343-2
Substandard and falsified medical products. WHO. Available from: https://www.who.int/health-topics/substandard-and-falsified-medical-products#tab=tab_1
Лебедь СО, Немченко АС. Експертна оцінка боротьби з фальсифікацією лікарських засобів в Україні. Фарм. журнал. 2020; 75 (4):30-38.
Немченко АС, Лебедь СО. Аналіз стану та проблем боротьби з розповсюдженням фальсифікованих лікарських засобів. Соціальна фармація в охороні здоров’я. 2020;6 (3):34-40.
Тулегенова АР, Дильбарханова ЖР, Сокуренко ИА. Анализ результатов опроса фармацевтических работников по проблеме фальсификации лекарственных препаратов и их незаконного оборота на фармацевтическом рынке Республики Казахстан, Управління, економіка та забезпечення якості в фармації. 2018; 1 (53): 63-71.
Каштанова ОА. Научное обоснование оптимизации аудита процессов хранения лекарственных средств на региональном уровне (на примере Астраханской области) [диссертация]. Курск, 2013. 230 с.
Alwon BM. Developing a national strategy for combating counterfeit medicines : PhD Thesis. School of Pharmacy University of East Anglia. 2015, 366 р. Available from: https://ueaeprints.uea.ac.uk/id/eprint/59256/1/Bassam_Alwon-PhD_Thesis.pdf.
Nedelkov N, Yordanov E, Hristov E, Petkova V, Ognianov S, Andreevska K et al. Serialization and Verification of Medicinal Products – A Pilot Study Among Pharmacists in Bulgaria. Acta Med. Bulg. 2019;XL VI (3):18-22.
Khokhlova NA, Demyanenko VG, Breusova SV. Study for the reasons of counterfeit drugs incoming into pharmacies of Kharkov city. Actual questions оf development оf new drugs : abstr. XX intern. scient. and pract. conf.; 2014 Apr 22-23; Kharkiv. Kharkiv: NUPh; 2014. p. 324.
До відома споживачів лікарських засобів. Державна служба України з лікарських засобів та контролю за наркотиками. Available from: https://www.dls.gov.ua/dicls_news/%D0%B4%D0%BE-%D0%B2%D1%96%D0%B4%D0%BE%D0%BC%D0%B0-%D1%81%D0%BF%D0%BE%D0%B6%D0%B8%D0%B2%D0%B0%D1%87%D1%96%D0%B2-%D0%BB%D1%96%D0%BA%D0%B0%D1%80%D1%81%D1%8C%D0%BA%D0%B8%D1%85-%D0%B7%D0%B0%D1%81%D0%BE-2/
WHO Global Surveillance and Monitoring System for substandard and falsified medical products. WHO, 2017. Available from: https://www.who.int/publications/i/item/978-92-4-151342-5
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Pharmaceutical Review
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The authors who publish their materials in this journal agree with the following terms:
- Authors reserve the right to authorship of their work and assign to the journal the right to first publish this work under the terms of the Creative Commons Attribution License, which allows other persons to freely distribute the published work with a mandatory reference to the authors of original work and the first publication of work in this journal
. - Authors have the right to make independent extra-exclusive work agreements in the form they are published by this journal (for example, posting work in an electronic repository of an institution or publishing as part of a monograph), provided that the link to the first publication of the work in this journal is maintained.
Journal policy allows and encourages publication of manuscripts on the Internet (for example, in institutions repositories or on personal websites), both before the publication of this manuscript and during its editorial review, as it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the citation of the published work (see The Effect of Open Access).
